Buffett and Munger built investing success by focusing on business fundamentals, not just financial ratios. This is how they ...
Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...
IB World School with CBSE, offering holistic, values-led education, global best practices, sports, boarding, and leadership learning.
For the development of critical transmission infrastructure in Kenya, Power Grid Corporation of India Limited (POWERGRID), in ...
Zacks Investment Research on MSN
Citigroup stock outshines Mag-7 in 2025: What awaits in 2026?
Shares of Citigroup, Inc. C have significantly outshone the Mag-7 tech giants in 2025, with shares surging 62.9%. Investor confidence is reinforced by tangible progress in the bank’s multi-year ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...
Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes ...
VnExpress International on MSN
Police raid facility illegally keeping tigers and leopards in HCMC
Environment police under the Ministry of Public Security, in coordination with Ho Chi Minh City officers, raided a wildlife ...
The Tribunal noted non-payment of significant dues, including EDC payable to ADA and tax liabilities, and admitted the Section 10 application, commencing CIRP and appointing an ...
Trofinetide is a synthetic analog of the N-terminal tripeptide of insulin-like growth factor 1. The mechanism by which trofinetide exerts therapeutic effects in patients with Rett syndrome is unknown.
Berlin, Germany, and Research Triangle Park, N.C., USA, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Not intended for UK Media Product designation supports development of innovative investigational gene ...
This article picked by a teacher with suggested questions is part of the Financial Times free schools access programme. Details/registration here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results